Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation
Status:
Completed
Trial end date:
2019-07-09
Target enrollment:
Participant gender:
Summary
Cornea transplant recipients who are using topical corticosteroids long-term to prevent
transplant rejection will be randomized to use netarsudil or placebo.